Woman Kills Son, Because She Wanted A Girl-Child

A woman in India has been arrested for allegedly killing her 10-month-old son after the infant’s body was found in a water-filled drum outside her house, police said on Monday.

A senior police official said the woman, in contrast to the general narrative on female infanticide, has revealed that she killed her son because she wanted a girl child.

The child, Prem Parameshwar Erande, had allegedly gone missing from the house in Paithankheda village of Paithan tehsil in Aurangabad district early Sunday, police said.

The woman, Vedika Erande, had filed a complaint with Bidkin police station following her son’s disappearance.


In her complaint, she stated that her child had possibly been abducted, the official said.

“A few hours after the complaint was filed, a police canine, on Sunday evening, zeroed in on the child lying dead inside a drum filled with water in the verandah of Vedika’s house,” Assistant Inspector Pandit Sonawane of Bidkin police station said.“Since the death looked suspicious, we questioned Vedika and another relative. The accused’s answers were unconvincing,” Sonawane said.“It was revealed during questioning that Vedika killed the 10-month-old Prem. She told us that she already has an elder son and was expecting a daughter when she was pregnant with Prem. This is the reason behind her committing this act, she has told us,” Sonawane added.The woman has been charged under Section 302 (murder) of the Indian Penal Code.

Mercy Johnson Shed Tears As She Buries Mom [Photos]

Mercy Johnson has laid her mom to rest after she passed on last month. The mom of three yesterday shared photos from her mother’s burial, including one where she shed tears.

US Approves First Cannabis-Based Drug

                    

The U.S. health regulator approved GW Pharmaceuticals Plc’s epilepsy treatment on Monday, making it the first cannabis-based drug to win approval in the country and opening floodgates for more research into the medicinal properties of cannabis.

The drug’s approval permits its use in patients aged two years and older with Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS), rare childhood-onset forms of epilepsy that are among the most resistant to treatment.

“This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies,” said Food and Drug Administration Commissioner Scott Gottlieb.

The drug, Epidiolex, is made up of cannabidiol (CBD), one of the hundreds of molecules found in the marijuana plant, and contains less than 0.1 percent of tetrahydrocannabinol (THC), the psychoactive component that makes people high.